Serologic response to Mannheimia haemolytica in calves concurrently inoculated with inactivated or modified-live preparations of m haemolytica and viral combination vaccines containing modified-live bovine herpesvirus type 1

American Journal of Veterinary Research

Volumn 72, Issue 11, 2011, Pages 1541-1549

  Cortese, Victor S ^a   Seeger, Jon T ^a   Stokka, Gerald S ^a   Hunsaker, Breck D ^b   Lardy, Gregory P ^c   Weigel, Daniel J ^a   Brumbaugh, Gordon W ^a  

^a PFIZER INC   (United States)

^b Horton Feedlot and Research Center   (United States)

^c NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; BACTERIUM ANTIBODY; BOVINE HERPES VIRUS 1 VACCINE; LEUKOTOXIN ANTIBODY; MANNHEIMIA HAEMOLYTICA VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CALF (BOVINE); CONTROLLED STUDY; NONHUMAN; SEROLOGY; VACCINATION;

AGE FACTORS; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; BACTERIAL TOXINS; BACTERIAL VACCINES; CATTLE; CATTLE DISEASES; EXOTOXINS; FEMALE; HERPESVIRUS 1, BOVINE; IMMUNIZATION; MALE; MANNHEIMIA HAEMOLYTICA; RANDOM ALLOCATION; RESPIRATORY TRACT INFECTIONS; VACCINES, COMBINED; VACCINES, INACTIVATED; VIRAL VACCINES;

ANIMALIA; BOVINE HERPESVIRUS 1; MANNHEIMIA HAEMOLYTICA;

EID: 80054934958     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.72.11.1541     Document Type: Article

References (23)

1. Drake JR, Sant AJ. The mechanism of class II processing: establishment of a peptide class II hierarchy. In: Frelinger A, ed. Immunodominance-the choice of the immune system. Weinheim, Germany: Wiley-VCH Verlag Gmbh & Co, 2006;31-56.
2. Sette A, Sundaram R. The phenomenon of immunodominance: speculation on the nature of immunodominance. In: Frelinger A, ed. Immunodominance-the choice of the immune system. Weinheim, Germany: Wiley-VCH Verlag Gmbh & Co, 2006;57-72.
3. Miller PJ, Collins EJ. Class I MHC antigen processing. In: Frelinger A, ed. Immunodominance-the choice of the immune system. Weinheim, Germany: Wiley-VCH Verlag Gmbh & Co, 2006;3-30.
4. Eskola J, Olander RM, Hovi T, et al. Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenza type B conjugate vaccine. Lancet 1996;348:1688-1692.
5. Linhares AC, Bresee JS. Rotavirus vaccines and vaccination in Latin America. Pan Am J Public Health 2000;8:305-331.
6. Harland RJ, Potter AA, van Drunen Little-van den Hurk S, et al. The effect of subunit or modified live bovine herpesvirus-1 vaccines on the efficacy of a recombinant Pasteurella haemolytica vaccine for the prevention of respiratory disease in feedlot calves. Can Vet J 1992;33:734-741.
7. Wankel LE, Marston TT, Stokka GL, et al. Effects of vaccinating beef dams precalving and calves preweaning with a Pasteurella haemolytica vaccine, in Proceedings. Cattlemen's Day 2001;29-30.
8. A study to determine interference of MLV IBR vaccine on titer response to Mannheimia haemolytica bacterin/toxoid. Boehringer Ingelheim technical bulletin TB06-127. St Joseph, Mo: Boehringer Ingelheim, 2006.
9. Odendaal MW, Morris S, Du Preez E, et al. The humoral immune response in cattle after immunization with a multivalent IBR/PI3/Pasteurella haemolytica Al leukotoxin vaccine. Onderstepoort J Vet Res 1997;64:205-212.
10. Clinkenbeard KD, Clarke CR, Morton RJ, et al. Role of Pasteurella haemolytica leukotoxin in virulence and immunity in shipping fever pneumonia. Compend Contin Educ Pract Vet 1992;14:1249-1262.
11. Confer AW, Panciera RJ, Mosier DA. Bovine pneumonic pasteurellosis: immunity to Pasteurella haemolytica. J Am Vet Med Assoc 1988;93:1308-1316.
12. Confer AW, Simons KR, Panciera RJ, et al. Serum antibody response to carbohydrate antigens of Pasteurella haemolytica serotype 1: relation to experimentally induced bovine pneumonic pasteurellosis. Am J Vet Res 1989;50:98-105.
13. Mosier DA, Panciera RJ, Rogers GA, et al. Comparison of serologic and protective responses induced by two Pasteurella vaccines. Can J Vet Res 1998;62:178-182.
14. Tigges MG, Loan RW. Serum antibody response to purified Pasteurella haemolytica capsular polysaccharide in cattle. Am J Vet Res 1993;54:856-860.
15. Srinand S, Ames TR, Maheswaran SK, et al. Efficacy of various vaccines against pneumonic pasteurellosis in cattle: a metaanalysis. Prev Vet Med 1995;25:7-17.
16. Confer AW, Fulton RW, Clinkenbeard KD, et al. Duration of serum antibody responses following vaccination and revaccination of cattle with non-living commercial Pasteurella haemolytica vaccines. Vaccine 1998;16:1962-1970.
17. Clinkenbeard KD, Clarke CR, Hague CM, et al. Pasteurella haemolytica leukotoxin-induced synthesis of eicosanoids by bovine neutrophils in vitro. J Leukocyte Biol 1994;56:644-649.
18. Confer AW, McCraw RD, Durham JA, et al. Serum antibody responses of cattle to iron-regulated outer membrane proteins of Pasteurella haemolytica A1. Vet Immunol Immunopathol 1995;47:101-110.
19. Ficken MD, Ellsworth MA, Tucker CM. Evaluation of the efficacy of a modified-live combination vaccine against abortion caused by virulent bovine herpesvirus type 1 in a one-year duration-of-immunity study. Vet Ther 2006;7:275-282.
20. Scatozza F. Immunogenicity of vaccines against swine influenza under different field conditions. Doc Vet 1995;2:45-53.
21. Lowe F, Zuckermann FA, Firkins LD, et al. Immunologic responses and reproductive outcomes following exposure to wild-type or attenuated porcine reproductive and respiratory syndrome virus in swine under field conditions. J Am Vet Med Assoc 2006;228:1082-1088.
22. Pfizer Animal Health study. Report No. 3138R-60-04-381. New York: Pfizer Inc, 2005.
23. Pfizer Animal Health study. Report No. 2134B-60-99-064. New York: Pfizer Inc, 1999.